Nuño Martínez, Néstor
Wallenborn, Jordyn
Mäusezahl, Daniel
Hartinger, Stella M.
Muela Ribera, Joan
Funding for this research was provided by:
UBS Optimus Foundation (UBS Optimus Foundation)
Grand Challenges Canada (Grand Challenges Canada)
Article History
Received: 23 November 2020
Accepted: 4 July 2021
First Online: 16 July 2021
Declarations
:
: Ethical approval for IHIP-2 trial (trial registry: ISRCTN26548981) was obtained from the ethics commissions of the Universidad Peruana Cayetano Heredia (UPCH) and the Cajamarca Regional Health Authority. Additional ethical approval for our study was obtained from the ethics commission of the UPCH (Ref. 61065). All women participants signed an informed consent form, and health personnel provided tape-recorded consent. We deleted community designations and participant names to ensure compliance with ethical principles of research. The information obtained from the study was treated confidentially.
: Not applicable.
: The authors declare that they have no competing interests.